首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart
【24h】

Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart

机译:蛋白酶激活受体2调节大鼠心脏的心肌缺血-再灌注损伤

获取原文
获取原文并翻译 | 示例
       

摘要

Protease-activated receptor-2 (PAR-2) is a member of seven trans- membrane domain G protein-coupled receptors adivated by proteo- lytic cleavage whose better known member is the thrombin receptor. The pathophysiological role of PAR-2 remains poorly understood. Because PAR-2 is involved in inflammatory and injury response events, we investigated the role of PAR-2 in experimental myocardial ischemia-reperfusion injury. We show for the fist time that PAR-2 activation proteds against reperfusion-injury. After PAR-2-activating peptide (2AP) infusion. we found a significant recovery of myocardial function and decrease in oxidation at reflow. Indeed, the glutethione Cycle (glutathiohe and oxidized glutathione) and lipid peroxidation analysis showed a reduced oxidative reperfusion-injury. Moreover, ischemic risk zone and creatine kinase release were decreased after PAR-2AP treatment. These events were coupled to elevation of PAR-2 and tumor necrosis factor α(tNF)α expression in both nuclear extracts and whole heart homogenates. The recovery of coronary flow was not reverted by L-nitroarginine mothylester, indicating a NO-inde- pendent pathway for this effect. Genistein, a tyrosine kinase inhibi- tor, did not revert the PAR-2AP effect. During early reperfusion injury in vivo not only oxygen radicals are produced but also numerous proinflammatory mediators promoting neutrophil and monocyte targeting. In this context, we show that TNFα and PAR-2 are invoved in signaling in pathophysiological conditions, such as myocardial ischemia-reperfusion. At the same time, because TNFα may exert pro-inflammatory actions and PAR-2 may constitute one of the first prot6dive mechanisms that signals a primary inflammatory response. our data support the concept that this network may regulate body responses to tissue injury.
机译:蛋白酶激活受体2(PAR-2)是通过蛋白水解裂解而分开的七个跨膜结构域G蛋白偶联受体的成员,其更广为人知的成员是凝血酶受体。 PAR-2的病理生理作用仍然知之甚少。因为PAR-2参与炎症和损伤反应事件,所以我们研究了PAR-2在实验性心肌缺血-再灌注损伤中的作用。我们首先展示了PAR-2的激活对再灌注损伤的保护作用。输注PAR-2-活化肽(2AP)后。我们发现心肌功能显着恢复并在回流时降低了氧化。实际上,谷胱甘肽循环(谷胱甘肽和氧化型谷胱甘肽)和脂质过氧化分析显示出减少的氧化再灌注损伤。此外,PAR-2AP治疗后缺血危险区和肌酸激酶释放降低。这些事件与核提取物和全心脏匀浆中PAR-2的升高和肿瘤坏死因子α(tNF)α的表达有关。 L-硝基精氨酸甲基酯不能恢复冠状动脉血流的恢复,表明这种作用与NO无关。 Genistein是一种酪氨酸激酶抑制剂,不能逆转PAR-2AP的作用。在早期的再灌注损伤期间,不仅体内产生氧自由基,而且还产生促进中性粒细胞和单核细胞靶向的多种促炎介质。在这种情况下,我们表明,TNFα和PAR-2在病理生理状况(例如心肌缺血-再灌注)的信号传导中参与。同时,由于TNFα可能发挥促炎作用,而PAR-2可能构成了信号转导原发性炎症反应的首批保护机制之一。我们的数据支持该网络可以调节机体对组织损伤的反应的概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号